G. Wain

Tamoxifen in patients with advanced epithelial ovarian cancer

N. Hacker, M. Friedlander, G. Gitsch, 1994, International Journal of Gynecologic Cancer.

Resection of bulky positive lymph nodes in patients with cervical carcinoma

N. Hacker, J. Nicklin, N. Hacker, 1994, International Journal of Gynecologic Cancer.

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Kylie L. Gorringe, S. Fox, P. Fasching, 2020, Modern Pathology.

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

S. Fox, K. Byth, S. Lade, 2018, Nature Communications.

A Comparison of Ovarian Cyst Aspirate Cytology and Histology. The Case Against Aspiration of Cystic Pelvic Masses

J. Nicklin, M. Eijkeren, N. Hacker, 1994 .

Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva.

N. Muñoz, M. Goodman, S. de Sanjosé, 2013, European journal of cancer.

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

S. Fox, S. Lade, N. Traficante, 2018, Nature Communications.